ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer.
Saved in:
| Title: | ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer. |
|---|---|
| Authors: | Gao B; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Wang X; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Long M; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Zhang F; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Wang Y; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Kumar R; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Veillard I; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Rueda BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States.; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Yeku O; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Lan L; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States. |
| Source: | NAR cancer [NAR Cancer] 2025 Sep 03; Vol. 7 (3), pp. zcaf031. Date of Electronic Publication: 2025 Sep 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
